Incruse Ellipta

Chronic Obstructive Pulmonary Disease
Treatment
1 FDA approval
20 Active Studies for Incruse Ellipta

What is Incruse Ellipta

UmeclidiniumThe Generic name of this drug
Treatment SummaryUmeclidinium is a medication used to treat chronic obstructive pulmonary disease (COPD). It is available as an inhaler and may be taken either as a standalone medicine or in combination with vilanterol, a long-acting beta2-agonist. Umeclidinium helps to open up the airways by blocking the M3 muscarinic receptor which prevents the binding of acetylcholine, therefore preventing bronchoconstriction. Regular use has been shown to improve lung function and reduce shortness of breath, coughing, and sputum production.
Anoro Elliptais the brand name
image of different drug pills on a surface
Incruse Ellipta Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Anoro Ellipta
Umeclidinium
2014
4

Approved as Treatment by the FDA

Umeclidinium, otherwise known as Anoro Ellipta, is approved by the FDA for 1 uses like Chronic Obstructive Pulmonary Disease .
Chronic Obstructive Pulmonary Disease
Used to treat Chronic Obstructive Pulmonary Disease (COPD) in combination with Fluticasone furoate

Effectiveness

How Incruse Ellipta works in the bodyUmeclidinium is a medication that helps to open up the airways in the lungs. It works by blocking the effects of the chemical messenger, acetylcholine, on certain receptors in the muscles of the airways. This leads to relaxation of the muscles and widening of the airways for easier breathing.

When to interrupt dosage

The recommended dosage of Incruse Ellipta is contingent upon the diagnosed affliction. The quantity of dosage varies, based on the method of administration featured in the table below.
Condition
Dosage
Administration
Chronic Obstructive Pulmonary Disease
, 0.0625 mg, 0.055 mg, 0.0625 mg/pump actuation
, Powder, Powder - Respiratory (inhalation), Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Oral, Aerosol, powder, Aerosol, powder - Oral

Warnings

Incruse Ellipta Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Umeclidinium may interact with Pulse Frequency
Severe Hypersensitivity Reactions
Do Not Combine
Umeclidinium may interact with Pulse Frequency
There are 20 known major drug interactions with Incruse Ellipta.
Common Incruse Ellipta Drug Interactions
Drug Name
Risk Level
Description
Aclidinium
Major
The risk or severity of adverse effects can be increased when Umeclidinium is combined with Aclidinium.
Astemizole
Major
The metabolism of Astemizole can be decreased when combined with Umeclidinium.
Cimetropium
Major
The risk or severity of adverse effects can be increased when Umeclidinium is combined with Cimetropium.
Clomipramine
Major
The metabolism of Clomipramine can be decreased when combined with Umeclidinium.
Clonidine
Major
The metabolism of Clonidine can be decreased when combined with Umeclidinium.
Incruse Ellipta Toxicity & Overdose RiskCommon side effects of umeclidinium include nasal inflammation, upper respiratory infection, cough, and joint pain. A rare side effect is atrial fibrillation, which occurs in fewer than 1% of patients. Umeclidinium should be used cautiously in those with glaucoma, enlarged prostate, or blocked bladder. Inhaled medications may cause a dangerous narrowing of the airways.
image of a doctor in a lab doing drug, clinical research

Incruse Ellipta Novel Uses: Which Conditions Have a Clinical Trial Featuring Incruse Ellipta?

98 active trials are being conducted to assess the efficacy of Incruse Ellipta for Chronic Obstructive Pulmonary Disease (COPD) Treatment.
Condition
Clinical Trials
Trial Phases
Chronic Obstructive Pulmonary Disease
84 Actively Recruiting
Phase 3, Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4

Incruse Ellipta Reviews: What are patients saying about Incruse Ellipta?

4.3Patient Review
7/26/2017
Incruse Ellipta for Prevention of Bronchospasms with Emphysema
4Patient Review
8/4/2017
Incruse Ellipta for Bronchospasm Prevention with COPD
I was using tudorza twice a day, but my pulse ox would only be at 90-91. My doctor gave me some samples of incruse and told me to try it instead. In just two days, I saw a significant improvement in my energy levels and my pulse ox while resting--it was up to 93-95! This medicine is definitely the reason why.
3.3Patient Review
2/7/2018
Incruse Ellipta for Bronchospasm Prevention with COPD
Incruse has helped my breathing, but at the cost of a very sore throat. I've tried various home remedies to no avail. It's also been giving me headaches. I'm worried about the long-term effects on my esophagus.
3Patient Review
11/16/2017
Incruse Ellipta for Bronchospasm Prevention with COPD
The phlegm has become very thick and difficult to cough up. My throat is constantly sore and burning. The taste is incredibly vile, like I just vomited!
2.3Patient Review
4/19/2018
Incruse Ellipta for Bronchospasm Prevention with COPD
I was on Spiriva for six years and it worked great, but then Medicare dropped it and I had to switch to Incruse. It's been terrible- my breathing is worse, I can barely walk around my house, and I'm constantly clearing my throat (even though there's no mucus). I also need to use oxygen more frequently now.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about incruse ellipta

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Symbicort and Incruse the same?

"Incruse Ellipta belongs to the anticholinergic drug class, while Symbicort is a combination of a steroid and a long-acting bronchodilator."

Answered by AI

Is Incruse a steroid inhaler?

"Advair Diskus is a dry powder inhaler that is typically taken twice a day by inhalation. Because Advair Diskus contains a steroid, it is important to rinse your mouth out after each dose."

Answered by AI

Is Incruse the same as Spiriva?

"Incruse Ellipta and Spiriva are two medications used to treat COPD. They are both classified as anticholinergics, which work by relaxing the muscles in the lungs to make breathing easier. Although they are similar, there are some key differences between the two medications."

Answered by AI

What does Incruse Ellipta do?

"INCRUSE is a prescription medicine that is taken once a day to treat chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis, emphysema, or both. Taking INCRUSE can help to improve breathing and reduce the number of flare-ups."

Answered by AI

Clinical Trials for Incruse Ellipta

Have you considered Incruse Ellipta clinical trials? We made a collection of clinical trials featuring Incruse Ellipta, we think they might fit your search criteria.
Have you considered Incruse Ellipta clinical trials? We made a collection of clinical trials featuring Incruse Ellipta, we think they might fit your search criteria.
Have you considered Incruse Ellipta clinical trials? We made a collection of clinical trials featuring Incruse Ellipta, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top